Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma-experience at two centres.
J Gastrointest Oncol. 2020 Apr;11(2):366-375. doi: 10.21037/jgo.2020.03.10.
J Gastrointest Oncol. 2020.
PMID: 32399277
Free PMC article.
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
Vogl UM, Andalibi H, Klaus A, Vormittag L, Schima W, Heinrich B, Kafka A, Winkler T, Öhler L.
Vogl UM, et al. Among authors: andalibi h.
BMC Cancer. 2019 Jan 8;19(1):28. doi: 10.1186/s12885-018-5240-6.
BMC Cancer. 2019.
PMID: 30621630
Free PMC article.
Item in Clipboard
Cite
Cite